Process validation and <i>in vitro</i>-<i>in vivo</i> evaluation of rosuvastatin calcium tablets-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Process validation and in vitro-in vivo evaluation of rosuvastatin calcium tablets

Published:2022-04-03 Issue:4 Volume:48 Page:140-145
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Xun Mingjin¹²,Guo Hui¹²,Cui Qingyan¹²,Zhang Guimin¹²,Feng Zhong¹²,Gui Lei¹²,Zhai Liying¹²

Affiliation:

1. National Engineering and Technology Research Center of Chirality Pharmaceutical, Lunan Pharmaceutical Group Co., Ltd, Linyi, China

2. International Pharmaceutical Engineering Lab. in Shandong Province, Shandong New Time Pharmaceutical Co., Ltd, Linyi, China

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2022.2101061

Reference21 articles.

1. Bioequivalence study of two rosuvastatin tablet formulations in healthy Indonesian subjects

2. Rosuvastatin

3. Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.

4. Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers

5. Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP